Highest-materiality recent filing
Hypha Labs dismisses Fruci & Associates, engages Astra Audit for FY2026
Board approved dismissal of Fruci & Associates II, PLLC and engagement of Astra Audit and Advisory, LLC for FY ending Sept 30, 2026.
Hypha Labs enters amended consulting agreement with CEO's entity for $120K/year
Amended and Restated Consulting Agreement with Duck's Nest Investments (wholly-owned by CEO A. Stone Douglass) effective Jan 1, 2025.
Hypha Labs increases authorized common shares to 880M and preferred to 70M
Certificate of Amendment filed with Nevada SOS, effective January 15, 2025.
On Dec 10, 2024, CEO A. Stone Douglass purchased 1,000 shares of Series C Preferred at $0.10/share, each carrying 200,000 votes.
Digipath renames to Hypha Labs after selling testing business; symbol change planned
Effective March 12, 2024, name changed from Digipath, Inc. to Hypha Labs, Inc. via Article 1 amendment.
President Todd Denkin resigns; A. Stone Douglass appointed President and CEO
Todd Denkin resigned as President of Digipath and Digipath Labs effective Feb 28, 2024 to pursue other opportunities.
Digipath completes sale of Digipath Labs' assets to DPL NV LLC for $2.3M
Sale closed on Feb 20, 2024, after Nevada CCB approval on Jan 18, 2024.
Digipath dismisses M&K CPAS, engages Fruci & Associates as new auditor for FY2023
Board approved dismissal of M&K CPAS and engagement of Fruci & Associates II, PLLC as independent auditor for fiscal year ending Sep 30, 2023.
Digipath agrees to sell cannabis testing lab assets for $2.3M; director resigns
Asset purchase price $2.3M cash; adjustments based on working capital above/below $150K.
Digipath sells 1,000 Series C Preferred shares to President Todd Denkin at $0.10/share
President Todd Denkin purchased 1,000 shares of Series C Preferred Stock for $100 total ($0.10 per share).
Terminated letter of intent with Evio, Inc. to acquire controlling interest in C3 Labs, a cannabis testing lab in Berkeley, CA.
Digipath exchanges 278K Series A for Series B preferred, raises $55.6K
Exchanged 278,000 shares of Series A Preferred for 278,000 shares of Series B Preferred with an institutional investor.
Digipath appoints A. Stone Douglass as CFO effective August 16, 2021
A. Stone Douglass, 74, appointed CFO; had been a director since July 1, 2021.
Digipath appoints Stone Douglass to board, Todd Denkin as President
Stone Douglass appointed to Board on July 1, 2021; received option for 1M shares at $0.06 exercise price.
The Company appointed A. Stone Douglass, the current Chairman, Chief Financial Officer and Secretary as well as a Director of the Company, to the additional roles of President and Chief Executive Officer of the Company effective February 29, 2024.
On February 28, 2024, Todd Denkin resigned his positions as President of Digipath, Inc. (the “Company”) and its wholly-owned subsidiary, Digipath Labs, Inc., effective the close of business on the same date to pursue other professional opportunities.
On May 2, 2023, Bruce Raben submitted a letter to the Company resigning from his position as a director of the Company.
On August 16, 2021, A. Stone Douglass, 74, who has served as a member of the Board of Directors (the “Board”) of Digipath, Inc. (the “Company”) since July 1, 2021, was appointed to serve as the Company’s Chief Financial Officer.
On July 1, 2021, the Board appointed Todd Denkin to serve as the President of the Company.
On July 1, 2021, A. Stone Douglass, 73, was appointed to the Board of Directors (the “Board”) of Digipath, Inc. (the “Company”).
Max materiality 0.85 · Median 0.50 · Most common event other_material